An audit of glycaemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus

被引:0
|
作者
P. Downey
L. O’Shea
D. Dillon
M. Corbett
S. Sreenan
机构
[1] Blanchardstown Hospital,
关键词
D O I
10.1007/BF03170231
中图分类号
学科分类号
摘要
引用
收藏
页码:11 / 12
页数:1
相关论文
共 50 条
  • [21] Therapeutic inertia for glycaemic and blood pressure control in patients with type 2 diabetes mellitus and the cardiovascular consequences
    Paul, S.
    Shaw, J.
    Klein, K.
    DIABETOLOGIA, 2015, 58 : S63 - S63
  • [22] Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus
    Song, Do Kyeong
    Hong, Young Sun
    Sung, Yeon-Ah
    Lee, Hyejin
    PLOS ONE, 2024, 19 (02):
  • [23] Factors associated to glycaemic control in patients with type 2 diabetes
    Panarotto, Daniel
    Teles, Alisson Roberto
    Schumacher, Marina Verdi
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2008, 54 (04): : 314 - 321
  • [24] Intensive glycaemic control in type 2 diabetes mellitus: Does it improve cardiovascular outcomes?
    Reddy, Sagili Vijaya Bhaskar
    Bhatia, Eesh
    NATIONAL MEDICAL JOURNAL OF INDIA, 2011, 24 (01): : 21 - 27
  • [25] Association of adiponectin with dietary factors and cardiovascular risk factors in type 2 diabetes mellitus patients
    Attar, Mohammad Javad Hosseinzadeh
    Mohammadi, Somayeh
    Karimi, Mehrdad
    Hosseinnezhad, Arash
    Hosseini, Seyed Hossein
    Eshraghian, Mohammad Reza
    Jafari, Nazila
    Rahmani, Mazaher
    Karimi, Farzaneh
    Nezhad, Mohammad Kamali
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2013, 7 (01) : 3 - 7
  • [26] Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus
    M. E. Britton
    A. E. Denver
    V. Mohamed-Ali
    J. S. Yudkin
    Clinical Drug Investigation, 1998, 16 : 303 - 317
  • [27] Effects of glimepiride vs glibenclamide on ischaemic heart disease risk factors and glycaemic control in patients with type 2 diabetes mellitus
    Britton, ME
    Denver, AE
    Mohamed-Ali, V
    Yudkin, JS
    CLINICAL DRUG INVESTIGATION, 1998, 16 (04) : 303 - 317
  • [28] Modern approaches to management of cardiovascular risk factors at patients with diabetes mellitus type 2
    Verbovoy, A. F.
    Pashentseva, A. V.
    Verbovaya, N. I.
    Madyanov, I. V.
    Sharonova, L. A.
    Galkin, R. A.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (08) : 113 - 117
  • [29] Cardiovascular risk factors in patients with type 2 diabetes mellitus treated in an outpatient clinic
    Paola Garza-Lopez, Elisa
    Silva-Ruiz, Rosendo
    Vicente Rodriguez-Perez, Carlos
    SALUD PUBLICA DE MEXICO, 2017, 59 (06): : 604 - 605
  • [30] Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus
    Uslu, Sema
    Kebapci, Nur
    Kara, Mehmet
    Bal, Cengiz
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (01) : 113 - 120